346 related articles for article (PubMed ID: 17923781)
1. The role of diffusion-weighted imaging and the apparent diffusion coefficient (ADC) values for breast tumors.
Park MJ; Cha ES; Kang BJ; Ihn YK; Baik JH
Korean J Radiol; 2007; 8(5):390-6. PubMed ID: 17923781
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic Usefulness of Combination of Diffusion-weighted Imaging and T2WI, Including Apparent Diffusion Coefficient in Breast Lesions: Assessment of Histologic Grade.
Kim KW; Kuzmiak CM; Kim YJ; Seo JY; Jung HK; Lee MS
Acad Radiol; 2018 May; 25(5):643-652. PubMed ID: 29339079
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic performance of ADC for Non-mass-like breast lesions on MR imaging.
Imamura T; Isomoto I; Sueyoshi E; Yano H; Uga T; Abe K; Hayashi T; Honda S; Yamaguchi T; Uetani M
Magn Reson Med Sci; 2010; 9(4):217-25. PubMed ID: 21187691
[TBL] [Abstract][Full Text] [Related]
4. The role of diffusion weighted imaging as supplement to dynamic contrast enhanced breast MRI: Can it help predict malignancy, histologic grade and recurrence?
Roknsharifi S; Fishman MDC; Agarwal MD; Brook A; Kharbanda V; Dialani V
Acad Radiol; 2019 Jul; 26(7):923-929. PubMed ID: 30293819
[TBL] [Abstract][Full Text] [Related]
5. Optimization of apparent diffusion coefficient measured by diffusion-weighted MRI for diagnosis of breast lesions presenting as mass and non-mass-like enhancement.
Cheng L; Bai Y; Zhang J; Liu M; Li X; Zhang A; Zhang X; Ma L
Tumour Biol; 2013 Jun; 34(3):1537-45. PubMed ID: 23397543
[TBL] [Abstract][Full Text] [Related]
6. Apparent diffusion coefficient as an MR imaging biomarker of low-risk ductal carcinoma in situ: a pilot study.
Iima M; Le Bihan D; Okumura R; Okada T; Fujimoto K; Kanao S; Tanaka S; Fujimoto M; Sakashita H; Togashi K
Radiology; 2011 Aug; 260(2):364-72. PubMed ID: 21633054
[TBL] [Abstract][Full Text] [Related]
7. Role of diffusion-weighted MRI: predicting axillary lymph node metastases in breast cancer.
Chung J; Youk JH; Kim JA; Gweon HM; Kim EK; Ryu YH; Son EJ
Acta Radiol; 2014 Oct; 55(8):909-16. PubMed ID: 24234236
[TBL] [Abstract][Full Text] [Related]
8. Characterization of ductal carcinoma in situ on diffusion weighted breast MRI.
Rahbar H; Partridge SC; Eby PR; Demartini WB; Gutierrez RL; Peacock S; Lehman CD
Eur Radiol; 2011 Sep; 21(9):2011-9. PubMed ID: 21562806
[TBL] [Abstract][Full Text] [Related]
9. Intravoxel incoherent motion (IVIM) in evaluation of breast lesions: comparison with conventional DWI.
Liu C; Liang C; Liu Z; Zhang S; Huang B
Eur J Radiol; 2013 Dec; 82(12):e782-9. PubMed ID: 24034833
[TBL] [Abstract][Full Text] [Related]
10. Diffusion-weighted imaging (b value = 1500 s/mm(2)) is useful to decrease false-positive breast cancer cases due to fibrocystic changes.
Ochi M; Kuroiwa T; Sunami S; Murakami J; Miyahara S; Nagaie T; Oya M; Yabuuchi H; Hatakenaka M
Breast Cancer; 2013 Apr; 20(2):137-44. PubMed ID: 22161277
[TBL] [Abstract][Full Text] [Related]
11. Diffusion-weighted MR imaging: role in the differential diagnosis of breast lesions.
Altay C; Balci P; Altay S; Karasu S; Saydam S; Canda T; Dicle O
JBR-BTR; 2014; 97(4):211-6. PubMed ID: 25603628
[TBL] [Abstract][Full Text] [Related]
12. Apparent diffusion coefficients of breast tumors: clinical application.
Hatakenaka M; Soeda H; Yabuuchi H; Matsuo Y; Kamitani T; Oda Y; Tsuneyoshi M; Honda H
Magn Reson Med Sci; 2008; 7(1):23-9. PubMed ID: 18460845
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic performance of minimum apparent diffusion coefficient value in differentiating the invasive breast cancer and ductal carcinoma
Zhao S; Shao G; Chen P; Li L; Yang Y; Zhao X; Guo W
J Cancer Res Ther; 2019; 15(4):871-875. PubMed ID: 31436245
[TBL] [Abstract][Full Text] [Related]
14. Diffusion-weighted imaging with fat suppression using short-tau inversion recovery: Clinical utility for diagnosis of breast lesions.
Ouyang Z; Ouyang Y; Zhu M; Lu Y; Zhang Z; Shi J; Li X; Ren G
Clin Radiol; 2014 Aug; 69(8):e337-44. PubMed ID: 24837698
[TBL] [Abstract][Full Text] [Related]
15. Comparative utility of MRI perfusion with MSIDR and DWIBS for the characterization of breast tumors.
Zhang B; Zhu B; Li M; Yuan L; Yuan L; Zhang X; Yu H; Li C; Lu F; Zhou Z; Zhuang X
Acta Radiol; 2012 Jul; 53(6):607-14. PubMed ID: 22761342
[TBL] [Abstract][Full Text] [Related]
16. Breast lesions: evaluation with dynamic contrast-enhanced T1-weighted MR imaging and with T2*-weighted first-pass perfusion MR imaging.
Kvistad KA; Rydland J; Vainio J; Smethurst HB; Lundgren S; Fjøsne HE; Haraldseth O
Radiology; 2000 Aug; 216(2):545-53. PubMed ID: 10924584
[TBL] [Abstract][Full Text] [Related]
17. Quantitative diffusion-weighted imaging as an adjunct to conventional breast MRI for improved positive predictive value.
Partridge SC; DeMartini WB; Kurland BF; Eby PR; White SW; Lehman CD
AJR Am J Roentgenol; 2009 Dec; 193(6):1716-22. PubMed ID: 19933670
[TBL] [Abstract][Full Text] [Related]
18. Differentiating benign and malignant inflammatory breast lesions: Value of T2 weighted and diffusion weighted MR images.
Kanao S; Kataoka M; Iima M; Ikeda DM; Toi M; Togashi K
Magn Reson Imaging; 2018 Jul; 50():38-44. PubMed ID: 29545213
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic accuracy of diffusion-weighted MRI for differentiation of cervical cancer and benign cervical lesions at 3.0T: Comparison with routine MRI and dynamic contrast-enhanced MRI.
Kuang F; Yan Z; Li H; Feng H
J Magn Reson Imaging; 2015 Oct; 42(4):1094-9. PubMed ID: 25824638
[TBL] [Abstract][Full Text] [Related]
20. [Application of diffusion weighted magnetic resonance imaging to differential diagnosis of breast diseases].
Luo JD; Liu YY; Zhang XL; Shi LC
Ai Zheng; 2007 Feb; 26(2):168-71. PubMed ID: 17298747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
